On the public citation graph
Biotech‐Pharmaceutical Alliances as a Signal of Asset and Firm Quality
0 signed · 171 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/smj.4250090403openalex-snapshot
Joint ventures: Theoretical and empirical perspectives
inferredcites →https://doi.org/10.1016/s0167-6296(98)00025-3openalex-snapshot
The logged dependent variable, heteroscedasticity, and the retransformation problem
inferredcites →https://doi.org/10.1111/1467-6451.00066openalex-snapshot
The Control of Technology Alliances: An Empirical Analysis of the Biotechnology Industry
inferredcites →https://doi.org/10.1111/j.1540-6261.1976.tb01907.xopenalex-snapshot
ON THE EFFICIENCY OF COMPETITIVE STOCK MARKETS WHERE TRADES HAVE DIVERSE INFORMATION
inferredcites →https://doi.org/10.1111/j.1540-6261.1983.tb03840.xopenalex-snapshot
On the Positive Role of Financial Intermediation in Allocation of Venture Capital in a Market with Imperfect Information
inferredcites →https://doi.org/10.1111/j.1540-6261.1993.tb04710.xopenalex-snapshot
The Pricing of Initial Public Offerings: A Dynamic Model with Information Production
inferredcites →https://doi.org/10.1111/j.1540-6261.1994.tb04420.xopenalex-snapshot
Investment Bank Reputation, Information Production, and Financial Intermediation
inferredcites →https://doi.org/10.1177/009286150003400425openalex-snapshot
New Drug Innovation and Pharmaceutical Industry Structure: Trends in the Output of Pharmaceutical Firms
inferredcites →https://doi.org/10.2139/ssrn.41980openalex-snapshot
R&D Performance, Collaborative Arrangements and the Market for Know-How: A Test of the "Lemons" Hypothesis in Biotechnology
inferredcites →https://doi.org/10.2307/2326770openalex-snapshot
Informational Asymmetries, Financial Structure, and Financial Intermediation
inferredcites →https://doi.org/10.2307/2327206openalex-snapshot
Information Production, Market Signalling, and the Theory of Financial Intermediation
inferredcites →https://doi.org/10.3386/w7464openalex-snapshot
Do Equity Financing Cycles Matter? Evidence from Biotechnology Alliances
inferredcites →https://doi.org/10.3386/w8841openalex-snapshot
How Much Should We Trust Differences-in-Differences Estimates?
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4826690openalex-extracted
A Real Options Analysis of Contractual Structures of R&d Alliances: Growth Versus Deferral Choice Under Uncertainty
inferred← citeshttps://doi.org/10.1002/9780470750025.ch24openalex-snapshot
Financing Strategies for Industrial‐Scale Biofuel Production and Technology Development Start‐Ups
inferred← citeshttps://doi.org/10.1002/9781118258996.ch27openalex-snapshot
How Initial Public Offerings Affect M&A Markets: The Dual Tracking Phenomenon
inferred← citeshttps://doi.org/10.1002/9781118266908.ch12openalex-snapshot
Time to Grow Up: Large Sample Evidence on the Maturation Dynamics of Private Venture‐Backed Firms
inferred← citeshttps://doi.org/10.1002/mde.1343openalex-snapshot
Mergers and acquisitions in the pharmaceutical and biotech industries
inferred← citeshttps://doi.org/10.1002/mde.2540openalex-snapshot
Partner Characteristics, Information Asymmetry, and the Signaling Effects of Joint Ventures
inferred← citeshttps://doi.org/10.1002/sej.1221openalex-snapshot
Strategic Alliances of Entrepreneurial Firms: Value Enhancing Then Value Destroying
inferred← citeshttps://doi.org/10.1002/sej.70008openalex-snapshot
Upfront payments to venture‐backed startups in technology alliances: Bargaining effects of VC affiliations
inferred← citeshttps://doi.org/10.1002/smj.2064openalex-snapshot
Executive preferences for governance modes and exchange partners: An information economics perspective
inferred← citeshttps://doi.org/10.1002/soej.12221openalex-snapshot
The Impact of R&D Cooperations and Mergers in Pharmaceuticals on Research Activities and Drugs Offered on the Market
inferred← citeshttps://doi.org/10.1002/sres.861openalex-snapshot
A framework for managing knowledge in strategic alliances in the biotechnology sector
inferred← citeshttps://doi.org/10.1007/s00500-019-04288-6openalex-snapshot
IT2-based multidimensional evaluation approach to the signaling: investors’ priorities for the emerging industries
inferred← citeshttps://doi.org/10.1007/s10198-015-0758-xopenalex-snapshot
Why trash don’t pass? pharmaceutical licensing and safety performance of drugs
inferred← citeshttps://doi.org/10.1007/s11156-020-00879-9openalex-snapshot
The value of innovation and the spillover effect on alliance partners
inferred← citeshttps://doi.org/10.1007/s11187-009-9247-xopenalex-snapshot
Strategic alliances by venture capital backed firms: an empirical examination
inferred← citeshttps://doi.org/10.1007/s11187-025-01003-8openalex-snapshot
Pre-entry experience, knowledge inheritance, and entrepreneurial resource mobilization
inferred← citeshttps://doi.org/10.1007/s11301-017-0131-5openalex-snapshot
The determinants of startup valuation in the venture capital context: a systematic review and avenues for future research
inferred← citeshttps://doi.org/10.1007/s11575-025-00574-8openalex-snapshot
International Corporate Development Activities and Information Disclosures in Earnings Calls
inferred← citeshttps://doi.org/10.1007/s11579-007-0005-zopenalex-snapshot
Valuing the option to invest in an incomplete market
inferred← citeshttps://doi.org/10.1007/s12247-012-9131-0openalex-snapshot
The Role of Pre-IPO Financial Indicators and Intermediaries in Aftermarket Performance and Survival in the US Biopharmaceutical Market
inferred← citeshttps://doi.org/10.1016/j.drudis.2008.07.001openalex-snapshot
On the stage division mechanism in pharmaceuticals development processes
inferred← citeshttps://doi.org/10.1016/j.drudis.2022.08.001openalex-snapshot
Biopharmaceutical R&D outsourcing: Short-term gain for long-term pain?
inferred← citeshttps://doi.org/10.1016/j.drudis.2025.104394openalex-snapshot
Sustaining pharmaceutical innovation after the Inflation Reduction Act: trends in R&D spending, equity investment, and business development
inferred← citeshttps://doi.org/10.1016/j.econmod.2022.105897openalex-snapshot
Do liquidity constraints affect the investment decisions of California hospitals?
inferred← citeshttps://doi.org/10.1016/j.ejor.2017.03.025openalex-snapshot
A real options game of alliance timing decisions in biopharmaceutical research and development
inferred← citeshttps://doi.org/10.1016/j.ibusrev.2026.102601openalex-snapshot
The influence of iterative orchestration on a firm’s ability to exploit inward FDI
inferred← citeshttps://doi.org/10.1016/j.ijpe.2013.02.004openalex-snapshot
Open innovation: A real option to restore value to the biopharmaceutical R&D
inferred← citeshttps://doi.org/10.1016/j.jbankfin.2014.01.033openalex-snapshot
Value of strategic alliances: Evidence from the bond market
inferred← citeshttps://doi.org/10.1016/j.jbusres.2012.05.019openalex-snapshot
Human and financial capital as determinants of biopharmaceutical IPO de-listings
inferred← citeshttps://doi.org/10.1016/j.jbusres.2024.114622openalex-snapshot
The interplay between product development failures and alliance portfolio properties in the formation of exploration versus exploitation alliances
inferred← citeshttps://doi.org/10.1016/j.jbusvent.2005.09.004openalex-snapshot
Determinants of the round-to-round returns to pre-IPO venture capital investments in U.S. biotechnology companies
inferred← citeshttps://doi.org/10.1016/j.jbusvent.2009.02.001openalex-snapshot
The dynamic impact of innovative capability and inter-firm network on firm valuation: A longitudinal study of biotechnology start-ups
inferred← citeshttps://doi.org/10.1016/j.jbusvent.2011.02.002openalex-snapshot
Alliance portfolios and shareholder value in post-IPO firms: The moderating roles of portfolio structure and firm-level uncertainty
inferred← citeshttps://doi.org/10.1016/j.jbusvent.2025.106482openalex-snapshot
Time to say goodbye? The role of SBIR funding, VC rounds, and initial alliance for director exit in new ventures
inferred← citeshttps://doi.org/10.1016/j.jcomm.2021.100224openalex-snapshot
Mine offtake contracting, strategic alliances and the equity market
inferred← citeshttps://doi.org/10.1016/j.jcorpfin.2006.08.001openalex-snapshot
The allocation of control rights in pharmaceutical alliances
inferred← citeshttps://doi.org/10.1016/j.jcorpfin.2021.101899openalex-snapshot
Let us work together: The impact of customer strategic alliances on IPO underpricing and post-IPO performance
inferred← citeshttps://doi.org/10.1016/j.jeconbus.2017.12.003openalex-snapshot
Does it pay to get connected? An examination of bank alliance network and bond spread
inferred← citeshttps://doi.org/10.1016/j.jedc.2011.05.001openalex-snapshot
Co-development ventures: Optimal time of entry and profit-sharing
inferred← citeshttps://doi.org/10.1016/j.jempfin.2012.06.002openalex-snapshot
Product market relationships and cost of bank loans: Evidence from strategic alliances
inferred← citeshttps://doi.org/10.1016/j.jfineco.2012.09.009openalex-snapshot
Strategic alliances, venture capital, and exit decisions in early stage high-tech firms
inferred← citeshttps://doi.org/10.1016/j.jhealeco.2004.09.006openalex-snapshot
Productivity in pharmaceutical–biotechnology R&D: the role of experience and alliances
inferred← citeshttps://doi.org/10.1016/j.jhealeco.2010.05.002openalex-snapshot
The impacts of the rise of Paragraph IV challenges on startup alliance formation and firm value in the pharmaceutical industry
inferred← citeshttps://doi.org/10.1016/j.jwb.2018.07.001openalex-snapshot
What and how do SMEs gain by going international? A longitudinal investigation of financial and intellectual resource growth
inferred← citeshttps://doi.org/10.1016/j.lrp.2017.05.002openalex-snapshot
The effects of pre-IPO corporate activity on newly-public firms' growth
inferred← citeshttps://doi.org/10.1016/j.lrp.2020.101995openalex-snapshot
An investigation of the attention effects of venture capitalist backing on entrepreneurial firms
inferred← citeshttps://doi.org/10.1016/j.lrp.2024.102427openalex-snapshot
Rethinking new venture growth: A time series cluster analysis of biotech startups’ heterogeneous growth trajectories
inferred← citeshttps://doi.org/10.1016/j.respol.2007.02.014openalex-snapshot
Modes of organizing biomedical innovation in the UK and US and the role of integrative and relational capabilities
inferred← citeshttps://doi.org/10.1016/j.respol.2011.01.006openalex-snapshot
Conveying quality and value in emerging industries: Star scientists and the role of signals in biotechnology
inferred← citeshttps://doi.org/10.1016/j.respol.2017.05.009openalex-snapshot
Dynamic impact of uncertainty on R&D cooperation formation and research performance: Evidence from the bio-pharmaceutical industry
inferred← citeshttps://doi.org/10.1016/j.respol.2018.01.009openalex-snapshot
R&D subsidies & external collaborative breadth: Differential gains and the role of collaboration experience
inferred← citeshttps://doi.org/10.1016/j.respol.2019.103902openalex-snapshot
Network failure: Biotechnology firms, clusters and collaborations far from the world superclusters
inferred← citeshttps://doi.org/10.1016/j.technovation.2007.02.007openalex-snapshot
Creating new technology through alliances: An empirical investigation of joint patents
inferred← citeshttps://doi.org/10.1016/j.technovation.2024.103102openalex-snapshot
How does market competition affect enterprise cooperative innovation? The moderating role of intellectual property protection and government subsidies
inferred← citeshttps://doi.org/10.1016/j.techsoc.2022.102194openalex-snapshot
The role of government-industry-academia partnership in business incubation: Evidence from new R&D institutions in China
inferred← citeshttps://doi.org/10.1016/s1048-4736(07)00009-4openalex-snapshot
Chapter 9 Introduction to finance and valuing early stage technology
inferred← citeshttps://doi.org/10.1021/bp070410sopenalex-snapshot
Strategic Biopharmaceutical Portfolio Development: An Analysis of Constraint‐Induced Implications
inferred← citeshttps://doi.org/10.1038/nnano.2017.1openalex-snapshot
Raising financing through strategic timing
inferred← citeshttps://doi.org/10.1057/jcb.2007.37openalex-snapshot
Biotechnology business models work: Evidence from the pharmaceutical marketplace
inferred← citeshttps://doi.org/10.1057/jibs.2014.3openalex-snapshot
Signals and international alliance formation: The roles of affiliations and international activities
inferred← citeshttps://doi.org/10.1057/palgrave.jcb.3050085openalex-snapshot
Biotechnology business models work: Evidence from the pharmaceutical marketplace
inferred← citeshttps://doi.org/10.1080/00036840500391146openalex-snapshot
What kind of German biotechnology start-ups do venture capital companies and corporate investors prefer for equity investments?
inferred← citeshttps://doi.org/10.1080/00036846.2011.562172openalex-snapshot
Do product innovation and news about the R&D process produce large price changes and overreaction? The case of pharmaceutical stock prices
inferred← citeshttps://doi.org/10.1080/00207543.2014.975858openalex-snapshot
New product development in new ventures: the quest for resources
inferred← citeshttps://doi.org/10.1080/09537325.2019.1664735openalex-snapshot
Multicomponent signals and financial constraints
inferred← citeshttps://doi.org/10.1080/09638180.2026.2642015openalex-snapshot
The Contagion Effect of Accounting Restatements on Strategic Alliance Partners
inferred← citeshttps://doi.org/10.1080/09654310801920631openalex-snapshot
How Venture Capital Shapes Emerging Bio-clusters—A Cross-country Comparison
inferred← citeshttps://doi.org/10.1080/10438590600661764openalex-snapshot
TECHNOLOGY, COOPERATION AND STOCK MARKET VALUE: AN EVENT STUDY OF NEW PARTNERSHIP ANNOUNCEMENTS IN THE BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRIES
inferred← citeshttps://doi.org/10.1080/13662716.2015.1133278openalex-snapshot
Science-based Firms Going Public: The Role of Patent Indicators and Top Management Teams
inferred← citeshttps://doi.org/10.1080/13691066.2021.1873210openalex-snapshot
Revealing the underlying drivers of CVC performance— a literature review and research agenda
inferred← citeshttps://doi.org/10.1080/13691066.2021.1894749openalex-snapshot
Technology spillovers and capital gains in corporate venture capital investments: evidence from the biopharmaceutical industry
inferred← citeshttps://doi.org/10.1080/13691066.2022.2086502openalex-snapshot
What do we know about startup-valuation drivers? A systematic literature review
inferred← citeshttps://doi.org/10.1093/oxfordhb/9780195391596.013.0022openalex-snapshot
From Ideas to Products: Financing Innovation and Getting Access to Innovation
inferred← citeshttps://doi.org/10.1093/oxfordhb/9780199742998.013.0003openalex-snapshot
Financing Research and Development
inferred← citeshttps://doi.org/10.1093/oxfordhb/9780199742998.013.0018openalex-snapshot
Mergers, Acquisitions, and Alliances
inferred← citeshttps://doi.org/10.1093/restud/rds012openalex-snapshot
Charity as a Substitute for Reputation: Evidence from an Online Marketplace
inferred← citeshttps://doi.org/10.1108/14691930910977806openalex-snapshot
Acquisitions reveal the hidden intellectual capital of pharmaceutical companies
inferred← citeshttps://doi.org/10.1108/978-1-80117-950-820231008openalex-snapshot
The Asymmetry of Expectations on the Outcomes of Strategic Alliances Between Biotechnology Start-Ups and Pharmaceutical Corporations
inferred← citeshttps://doi.org/10.1108/imds-09-2016-0359openalex-snapshot
Signaling in joint venture capital: a social network perspective
inferred← citeshttps://doi.org/10.1108/s0742-332220140000031002openalex-snapshot
Termination Payment Provisions in Acquisitions: An Information Economics Perspective
inferred← citeshttps://doi.org/10.1108/s0742-332220200000041028openalex-snapshot
Attracting Knowledge Workers to High-tech Ventures: A Signaling Perspective on Employee Mobility
inferred← citeshttps://doi.org/10.1109/icmse.2017.8574404openalex-snapshot
R&D Partner Selection Model and the Formation of Industrial R&D Networks Based on Cooperative Attractiveness
inferred← citeshttps://doi.org/10.1109/tems-isie.2018.8478492openalex-snapshot
Effects of relative power imbalance in the ecosystem on innovation
inferred← citeshttps://doi.org/10.1109/temscon.2017.7998351openalex-snapshot
Corporate venture capital as a real option in the markets for technology
inferred← citeshttps://doi.org/10.1111/1467-8551.12174openalex-snapshot
Network Positions and the Probability of Being Acquired: An Empirical Analysis in the Biopharmaceutical Industry
inferred← citeshttps://doi.org/10.1111/1911-3846.70084openalex-snapshot
Collaborative Innovation and R&D Disclosures: Evidence From Co‐Patents
inferred← citeshttps://doi.org/10.1111/emre.12428openalex-snapshot
Is it Really a Universal Phenomenon? ‐ Preferential Attachment in Alliance Networks
inferred← citeshttps://doi.org/10.1111/fima.12040openalex-snapshot
The Value of Strategic Alliances in Acquisitions and IPOs
inferred← citeshttps://doi.org/10.1111/jbfa.12008openalex-snapshot
Corporate Risk Management under Information Asymmetry
inferred← citeshttps://doi.org/10.1111/jems.12047openalex-snapshot
Strategic Alliances: Trading Ownership for Capabilities
inferred← citeshttps://doi.org/10.1111/joms.12217openalex-snapshot
Flow Signals: Evidence from Patent and Alliance Portfolios in the US Biopharmaceutical Industry
inferred← citeshttps://doi.org/10.1111/joms.12637openalex-snapshot
Acquirers’ Reception of Signals in M&A Markets: Effects of Acquirer Experiences on Target Selection
inferred← citeshttps://doi.org/10.1142/s1363919613400239openalex-snapshot
BIOPHARMACEUTICAL ALLIANCES AND COMPETITION: A REAL OPTIONS GAMES APPROACH
inferred← citeshttps://doi.org/10.1162/jeea.2007.5.4.823openalex-snapshot
Alliances between Competitors and Consumer Information
inferred← citeshttps://doi.org/10.1162/rest_a_00717openalex-snapshot
How Reliable Is the Market for Technology?
inferred← citeshttps://doi.org/10.1177/1476127014543629openalex-snapshot
The influences of capital market munificence on new-venture alliance formation in emerging industries
inferred← citeshttps://doi.org/10.1177/17407745241259112openalex-snapshot
Modeling impact of inflation reduction act price negotiations on new drug pipeline considering differential contributions of large and small biopharmaceutical companies
inferred← citeshttps://doi.org/10.1186/s13731-015-0027-3openalex-snapshot
On valuing biopharmaceutical product pipelines: an effectuation model and evidence
inferred← citeshttps://doi.org/10.1287/mnsc.1070.0703openalex-snapshot
Valuing R&D Projects in a Portfolio: Evidence from the Pharmaceutical Industry
inferred← citeshttps://doi.org/10.1287/mnsc.2015.2191openalex-snapshot
Competition and the Efficiency of Markets for Technology
inferred← citeshttps://doi.org/10.1287/orsc.1120.0805openalex-snapshot
Searching for Alliance Partners: Effects of Geographic Distance on the Formation of R&D Collaborations
inferred← citeshttps://doi.org/10.1287/orsc.2017.1124openalex-snapshot
Partner Selection in R&D Collaborations: Effects of Affiliations with Venture Capitalists
inferred← citeshttps://doi.org/10.1287/orsc.2017.1147openalex-snapshot
Network Prominence, Bargaining Power, and the Allocation of Value Capturing Rights in High-Tech Alliance Contracts
inferred← citeshttps://doi.org/10.1287/orsc.2018.1263openalex-snapshot
Safeguarding from the Sharks: Board Representation in Minority Equity Partnerships
inferred← citeshttps://doi.org/10.1287/stsc.2021.0127openalex-snapshot
Microfoundations of R&D Alliance Formation: The Interplay of Scientist Mobility and the Cooperative Context of Collaboration
inferred← citeshttps://doi.org/10.1509/jmkg.72.5.084openalex-snapshot
Flow Signals: How Patterns over Time Affect the Acceptance of Start-Up Firms
inferred← citeshttps://doi.org/10.1515/bsrj-2016-0002openalex-snapshot
The Potential of Biotechnology Investments in Selected Eastern European Countries: Lost Chances
inferred← citeshttps://doi.org/10.20525/ijrbs.v9i5.833openalex-snapshot
External funding and emergent technology inputs
inferred← citeshttps://doi.org/10.2139/ssrn.1323446openalex-snapshot
Conveying Quality and Value in Emerging Industries: Star Scientists and the Role of Learning in Biotechnology
inferred← citeshttps://doi.org/10.2139/ssrn.1424073openalex-snapshot
Control Rights and the Performance of Strategic Alliances
inferred← citeshttps://doi.org/10.2139/ssrn.1479272openalex-snapshot
Harvesting Biotechnology Ventures: Modeling the Probabilities for Alternatives Liquidity Events
inferred← citeshttps://doi.org/10.2139/ssrn.1716435openalex-snapshot
Explaining Preferences for Control Rights in Strategic Alliances: A Property Rights and Capabilities Perspective Approach
inferred← citeshttps://doi.org/10.2139/ssrn.1798403openalex-snapshot
Technology Commercialization Strategy in a Dynamic Context: Developing Specialized Complementary Assets in Entrepreneurial Firms
inferred← citeshttps://doi.org/10.2139/ssrn.2385909openalex-snapshot
The Impact of R&D Cooperations on Drug Variety Offered on the Market. Evidence from the Pharmaceutical Industry
inferred← citeshttps://doi.org/10.2139/ssrn.2429504openalex-snapshot
Technology Spillovers and Capital Gains in Corporate Venture Capital: Evidence from the Biopharmaceutical Industry
inferred← citeshttps://doi.org/10.2139/ssrn.2429508openalex-snapshot
Corporate Venture Capital, Competition, and Valuation in the Acquisition Market: Evidence from the Biopharmaceutical Industry
inferred← citeshttps://doi.org/10.2139/ssrn.2546667openalex-snapshot
Initial Public Offerings and Insider Participation: The Role of Venture Capitalists and Corporate Partners in the IPO Process
inferred← citeshttps://doi.org/10.2139/ssrn.3309496openalex-snapshot
Moving Beyond the Valley of Death: Regulation and Venture Capital Investments in Early-Stage Biopharmaceutical Firms
inferred← citeshttps://doi.org/10.2139/ssrn.3395614openalex-snapshot
Financial Contracting for Innovation: Property Rights in Action
inferred← citeshttps://doi.org/10.2139/ssrn.3444028openalex-snapshot
Wealth Effects of Farmout Arrangements in the Oil and Gas Industry
inferred← citeshttps://doi.org/10.2139/ssrn.3743805openalex-snapshot
The Organization of Innovation: Property Rights and the Outsourcing Decision
inferred← citeshttps://doi.org/10.2139/ssrn.419141openalex-snapshot
The Value Relevance of Financial Statements within and Across Private and Public Equity Markets
inferred← citeshttps://doi.org/10.2139/ssrn.4344356openalex-snapshot
The Contagion Effect of Accounting Restatements on Strategic Alliance Partners
inferred← citeshttps://doi.org/10.2139/ssrn.4630787openalex-snapshot
International Corporate Development Activities and Information Disclosures in Earnings Calls
inferred← citeshttps://doi.org/10.2139/ssrn.484385openalex-snapshot
Determinants of the Round-to-Round Returns to Pre-Ipo Venture Capital Investments in U.S. Biotechnology Companies
inferred← citeshttps://doi.org/10.2139/ssrn.546068openalex-snapshot
The Birth of German Biotechnology Industry: Did Venture Capital Run the Show?
inferred← citeshttps://doi.org/10.2139/ssrn.6844801openalex-snapshot
Promoters and Drags: Value Conversion Capability and the Dynamics of Value Capture in Biopharmaceutical Ventures Under Uncertainty
inferred← citeshttps://doi.org/10.2139/ssrn.722486openalex-snapshot
Alliances Between Competitors and Consumer Information
inferred← citeshttps://doi.org/10.2139/ssrn.7442905openalex-snapshot
Buyer Identity and Stock-Market Reactions to Cross-Border Drug Licensing: Evidence from A-Shares and Hong Kong
inferred← citeshttps://doi.org/10.2139/ssrn.871709openalex-snapshot
Time to Grow Up: Large Sample Evidence on the Maturation Dynamics of Private Venture-Backed Firms
inferred← citeshttps://doi.org/10.2139/ssrn.992868openalex-snapshot
Conveying Quality and Value in Emerging Industries: Star Scientists and the Role of Learning in Biotechnology
inferred← citeshttps://doi.org/10.2308/tar-2021-0359openalex-snapshot
Strategic Alliances and Lending Relationships
inferred← citeshttps://doi.org/10.23919/picmet.2019.8893765openalex-snapshot
The Key Success Factors of Biotech Start-Up Firms: Characteristics and Attributes of the Management Teams of High-Performing Biotech Start-Ups
inferred← citeshttps://doi.org/10.25439/rmt.27351417openalex-snapshot
Valuation models for Australian biotechnology companies
inferred← citeshttps://doi.org/10.26481/dis.20121206spopenalex-snapshot
The modern enterprise and the stock market : exploring the effects of uncertainty on the valuation and on the financing of innovation and intangibles
inferred← citeshttps://doi.org/10.29121/ijetmr.v11.i9.2024.1486openalex-snapshot
DISCLOSING MONETARY TERMS OF R&D ALLIANCES
inferred← citeshttps://doi.org/10.3386/w14602openalex-snapshot
Conveying Quality and Value in Emerging Industries: Star Scientists and the Role of Learning in Biotechnology
inferred← citeshttps://doi.org/10.3386/w18364openalex-snapshot
Explaining Preferences for Control Rights in Strategic Alliances: A Property Rights and Capabilities Perspective Approach
inferred← citeshttps://doi.org/10.3386/w28379openalex-snapshot
The Organization of Innovation: Incomplete Contracts and the Outsourcing Decision
inferred← citeshttps://doi.org/10.3386/w9615openalex-snapshot
Productivity in Pharmaceutical Biotechnology R&D: The Role of Experience and Alliances
inferred← citeshttps://doi.org/10.3390/jrfm14050191openalex-snapshot
Effects of R&D Investments and Market Signals on International Acquisitions: Evidence from IPO Firms
inferred← citeshttps://doi.org/10.3390/su13073599openalex-snapshot
Drug Discovery Firms and Business Alliances for Sustainable Innovation
inferred← citeshttps://doi.org/10.35536/ljb.2019.v8.i1.a2openalex-snapshot
Sovereign Wealth Funds’ Affiliation and Acquisition Premium: Evidence from the Asia-Pacific Region
inferred← citeshttps://doi.org/10.3926/ic.1978openalex-snapshot
Biotechnology firms, signals, and venture capital investment
inferred← citeshttps://doi.org/10.4000/rei.6357openalex-snapshot
Clusters et efficacité du capital-risque : une analyse des stratégies différenciées des fonds indépendants et des fonds industriels
inferred← citeshttps://doi.org/10.4018/978-1-59140-444-6.ch003openalex-snapshot
Partnering for Perfection
inferred← citeshttps://doi.org/10.5282/ubm/epub.13362openalex-snapshot
Can’t Buy Me Rights! The Contractual Structure of Asymmetrical Inter-firm Collaborations
inferred← citeshttps://doi.org/10.5465/ambpp.2012.13413abstractopenalex-snapshot
Costs and Benefits of Learning through Alliances for Entrepreneurial Firms
inferred← citeshttps://doi.org/10.5465/amj.2009.0549openalex-snapshot
Signals across Multiple Networks: How Venture Capital and Alliance Networks Affect Interorganizational Collaboration
inferred← citeshttps://doi.org/10.5465/amj.2010.0259openalex-snapshot
A Signaling Theory of Acquisition Premiums: Evidence from IPO Targets
inferred← citeshttps://doi.org/10.5539/ibr.v5n9p195openalex-snapshot
Understanding Life under Public Scrutiny: The U.S. Bio-pharmaceutical Industry Experience
inferred← citeshttps://doi.org/10.5547/01956574.44.4.ldisopenalex-snapshot
Common Stock Returns around Farmout Announcements in the Oil and Gas Industry
inferred← citeshttps://doi.org/10.70675/bf5fd98az25f7z4447z9e0dzd3d79b874a76openalex-snapshot
Le rôle des sociétés de capital-investissement dans la formation d'alliances stratégiques
inferred← citeshttps://doi.org/10.70675/dea2dc38zbd21z464cz8873zf47557b1b7ceopenalex-snapshot
Valuation of Start-up Companies
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.